• Marc E. Grossman
  • Lindy P. Fox
  • Carrie Kovarik
  • Misha Rosenbach


Hyalohyphomycosis (hyaline septate molds) is a term used to encompass a variety of less common yet medically opportunistic mycotic pathogens.1 They are non-dematiaceous molds or yeasts in which the tissue form is a colorless (hyaline) septate fungal hyphae with no pigment within the walls. This term is the counterpart to phaeohyphomycosis in which pathogens develop septate brown-walled hyphae in tissue. Hyalohypho­mycosis does not represent a recognizable clinical syndrome, but in histologic tissue sections they can be misidentified as Aspergillus. Hyaline septate molds are identified by their macroscopic and microscopic morphology in culture. However, greater than 50% of hyaline molds indentified in tissue cannot be cultivated for definitive identification. The members of this group are extremely heterogeneous and include Fusarium, Penicillium, Paecilomyces, Acremonium, Scopulariopsis, and Trichoderma.


Acquire Immune Deficiency Syndrome Chronic Granulomatous Disease Graft Versus Host Disease Tinea Pedis Fusarium Infection 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.



  1. 1.
    Walsh TJ, Groll A, Hiemenz J, et al. Infections due to emerging and uncommon medically important fungal pathogens. Clin Microbiol Infect. 2004;10 Suppl 1:48–66.PubMedCrossRefGoogle Scholar


  1. 2.
    Gupta Ad, Baran R, Summerbell RC. Fusarium infections of the skin. Curr Opin Infect Dis. 2000;13:121–8.PubMedCrossRefGoogle Scholar
  2. 3.
    Nucci M, Anaissie E. Fusarium infections in immunocompromised patients. Clin Microbiol Rev. 2007;20:695–704.PubMedCrossRefGoogle Scholar
  3. 4.
    Cooper C, MacPherson P, Angel JB. Liver toxicity resulting from syphilis and Jarish-Herxheimer reaction in cases of coinfection with HIV and hepatitis C virus. Clin Infect Dis. 2005;40(8):1211–2.PubMedCrossRefGoogle Scholar
  4. 5.
    Polk C, Forrest G, Cross A. Cellulitis in a patient with leukemia. Clin Infect Dis. 2007;44:1240–50.Google Scholar
  5. 6.
    Child FJ, Fuller LC, Higgins EM, du Vivier AWP, Mufti GJ. Cutaneous presentation of Fusarium solani infection in a bone marrow transplant recipient. J R Soc Med. 1996;89:647–8.PubMedGoogle Scholar
  6. 7.
    Bigley VH, Duarte RF, Gosling RD, et al. Fusarium dimerum infection in a stem cell transplant recipient treated successfully with voriconazole. Bone Marrow Transplant. 2004;34:815–7.PubMedCrossRefGoogle Scholar
  7. 8.
    Nucci M, Anaissie E. Cutaneous infection by Fusarium species in healthy and immunocompromised hostes: implications for diagnosis and management. Clin Infect Dis. 2002;35:909–19.PubMedCrossRefGoogle Scholar
  8. 9.
    Bordeaux JS, O’Brien M, Mahalingam M, Wiss K. Clinicopathologic challenge. Int J Dermatol. 2008;47:13–4.PubMedCrossRefGoogle Scholar
  9. 10.
    Bodey GP, Boktour M, Mays S, et al. Skin lesions associated with Fusarium infection. J Am Acad Dermatol. 2002;437:659–66.CrossRefGoogle Scholar
  10. 11.
    Musa MO, Al Eisa A, Halim M, et al. The spectrum of Fusarium infection in immunocompromised patients with haematological malignancies and in non-immunocompromised patients: a single institution experience over 10 years. Br J Haematol. 2000;108:544–8.PubMedCrossRefGoogle Scholar
  11. 12.
    Pérez-Pérez L, Pereiro Jr M, Sánchez-Aguilar D, Toribio J. Ulcerous lesions disclosing cutaneous infection with Fusarium solani. Acta Derm Venereol. 2007;87:422–4.PubMedCrossRefGoogle Scholar
  12. 13.
    Watsky KL. Sporotrichoid nodules in an immunocompromised host. Arch Dermatol. 1995;131:1329–30.PubMedCrossRefGoogle Scholar
  13. 14.
    Hamaki T, Kami M, Kishi A, et al. Vesicles as initial skin manifestations of disseminated fusariosis after non-myeloablative stem cell transplantation. Leuk Lymphoma. 2004;45:631–3.PubMedCrossRefGoogle Scholar
  14. 15.
    Zhang CZ, Fung MA, Eiser DB. Disseminated fusariosis presenting as panniculitis-like lesions on the legs of a neutropenic gril with acute lymphoblastic leukemia. Dermatol Online J. 2009;15:5.PubMedGoogle Scholar
  15. 16.
    Durand-Joly I, Alfandari S, Benchikh Z, et al. Successful outcome of disseminated Fusarium infection with skin localization treated with voriconazoleand amphotericin B-lipid complex in a patient with acute leukemia. J Clin Microbiol. 2003;41:4898–900.PubMedCrossRefGoogle Scholar
  16. 17.
    Helm TN, Longworth DL, Hall GS, et al. Case report and review of resolved fusariosis. J Am Acad Dermatol. 1990;23:393–8.PubMedCrossRefGoogle Scholar
  17. 18.
    Matsuda T, Matsumoto T. Disseminated hyalohyphomycosis in a leukemic patient. Arch Dermatol. 1986;123:1171–5.CrossRefGoogle Scholar
  18. 19.
    Yun SJ, Shin MG, Choi C, et al. Fatal disseminated angioinvasive Fusarium falciforme infection in a patient with acute myeloid leukemia. Br J Dermatol. 2007;157:407–9.PubMedCrossRefGoogle Scholar
  19. 20.
    Cocuroccia B, Gaido J, Gubinelli E, Annessi G, Girolomoni G. Localized cutaneous hyalohyphomycosis caused by Fusarium species infection in a renal transplant patient. J Clin Microbiol. 2003;41:905–7.PubMedCrossRefGoogle Scholar
  20. 21.
    Gardner JM, Nelson MM, Heffernan MP. Chronic cutaneous fusariosis. Arch Dermatol. 2005;141:794–5.PubMedCrossRefGoogle Scholar
  21. 22.
    Nucci M, Anaissie EJ, Queiroz-Telles F, et al. Outcome predictors of 84 patients with hematologic malignancies and Fusarium infection. Cancer. 2003;98:315–9.PubMedCrossRefGoogle Scholar

Penicillium marneffei (PM)

  1. 23.
    Ungpakorn P. Cutaneous manifestations of Penicillium morneffei infection. J Infect Dis. 2000;13:129–34.Google Scholar
  2. 24.
    Carey J, Hofflich H, Amre R, Protic J, Perlman DC. Penicillium marneffei infection in an immunocompromised traveler: a case report and literature review. J Travel Med. 2005;12:291–4.PubMedCrossRefGoogle Scholar
  3. 25.
    Supparatpinyo K, Chiewchanvit S, Hirunsri P, et al. Penicillium marneffei infection in patients infected with human immunodeficiency virus. Clin Infect Dis. 1992;14:871–4.PubMedCrossRefGoogle Scholar
  4. 26.
    Wu TC, Chan JW, Ng CK, et al. Clinical presentations and outcomes of Penicillium marneffei infections: a series from 1994 to 2004. Hong Kong Med J. 2008;12:103–9.Google Scholar
  5. 27.
    Duong TA. Infection due to Penicillium marneffei, an emerging ­pathogen: review of 155 reported cases. Clin Infect Dis. 1996;23:125–30.PubMedCrossRefGoogle Scholar
  6. 28.
    Walsh TJ, Groll AH. Emerging fungal pathogens: evolving challenges to immunocompromised patients for the twenty-first century. Transpl Infect Dis. 1999;1:247–61.PubMedCrossRefGoogle Scholar
  7. 29.
    Supparatpinyo K, Sirisanthana T. Disseminated Penicillium marneffei infection diagnosed on examination of a peripheral blood smear of a patient with human immunodeficiency virus infection. Clin Infect Dis. 1994;18:246–7.PubMedCrossRefGoogle Scholar


  1. 30.
    Itin PH, Frei R, Lautenschlager S, et al. Cutaneous manifestations of Paecilomyces lilacinus infection induced by a contaminated skin lotion in patients who are severely immunosuppressed. J Am Acad Dermatol. 1998;39:401–9.PubMedCrossRefGoogle Scholar
  2. 31.
    Orth B, Frei R, Itin PH, et al. Outbreak of invasive mycoses caused by Paecilomyces lilacinus from a contaminated skin lotion. Ann Intern Med. 1996;125:799–806.PubMedGoogle Scholar
  3. 32.
    Hall VC, Goyal S, Davis MD, Walsh JS. Cutaneous hyalohyphomycosis caused by Paecilomyces lilacinus: report of three cases and review of the literature. Int J Dermatol. 2004;43:648–53.PubMedCrossRefGoogle Scholar
  4. 33.
    Hilmarsdóttir I, Thorsteinsson SB, Asmundsson P, Bödvarsson M, Arnadóttir M. Cutaneous infection caused by Paecilomyces lilacinus in a renal transplant patient: treatment with voriconazole. Scand J Infect Dis. 2000;32:331–2.PubMedCrossRefGoogle Scholar
  5. 34.
    Lin WL, Lin WC, Chiu CS. Paecilomyces lilacinus cutaneous infection associated with peripherally inserted central catheter insertion. J Eur Acad Dermatol Venereol. 2008;22:1267–78.PubMedCrossRefGoogle Scholar
  6. 35.
    Safdar A. Progresssive cutaneous hyalohyphomycosis due to Paecilomyces lilacinus: rapid response to treatment with saspofungin and itraconzole. Clin Infect Dis. 2002;43:1415–7.CrossRefGoogle Scholar
  7. 36.
    Hecker MS, Weinberg JM, Bagheri B, et al. Cutaneous Paecilomyces lilacinus infection: report of two novel cases. J Am Acad Dermatol. 1997;37:270–1.PubMedCrossRefGoogle Scholar
  8. 37.
    Harris LF, Dan BM, Lefkowitz Jr LB, Alford RH. Paecilomyces cellulitis in a renal transplant patient: successful treatment with intravenous miconazole. South Med J. 1979;72:987.Google Scholar
  9. 38.
    Jade KB, Lyons MF, Gnann Jr JW. Paecilomyces lilacinus cellulitis in an immunocompromised patient. Arch Dermatol. 1986;122:1169.PubMedCrossRefGoogle Scholar
  10. 39.
    Castro LGM, Salebian A, Sotto MN. Hyalohyphomycosis by Paecilomyces lilacinus in a renal transplant patient and a review of human Paecilomyces species infection. J Med Vet Mycol. 1990;28:15.PubMedCrossRefGoogle Scholar
  11. 40.
    Silliman CC, Lawellin DW, Lohr JA, Rodgers BM, Donowitz LG. Paecilomyces lilacinus infection in a child with chronic granulamatous disease. J Infect. 1992;24:191.PubMedCrossRefGoogle Scholar
  12. 41.
    Wolfson JS, Sober AJ, Rubin RN. Dermatologic manifestations of infections in immunocompromised patients. Medicine (Baltimore). 1985;64:115–33.Google Scholar
  13. 42.
    Lott ME, Sheehan DJ, Davis LS. Paecilomyces lilacinus with a sporotrichoid pattern in a renal transplant patient. J Drugs Dermatol. 2007;6:436–9.PubMedGoogle Scholar
  14. 43.
    Lee J, Yew WW, Chiu CS, et al. Delayed sternotomy wound infection due to Paecilomyces variotii in a lung transplant recipient. J Heart Lung Transplant. 2002;21:1131–4.PubMedCrossRefGoogle Scholar
  15. 44.
    Pastor FJ, Guarro J. Clinical manifestations, treatment and outcome of Paecilomyces lilacinus. Clin Microbiol Infect. 2006;12:948–60.PubMedCrossRefGoogle Scholar


  1. 45.
    Schell WA, Perfect JR. Fatal, disseminated Acremonium strictum infection in a neutropenic host. J Clin Microbiol. 1996;34:1333–6.PubMedGoogle Scholar
  2. 46.
    Fincher RM, Fisher JF, Lovell RD, et al. Infection due to the fungus Acremonium (Cephalosporium). Medicine (Baltimore). 1991;70:398–409.Google Scholar
  3. 47.
    Chang YH, Huang LM, Hsueh PR, et al. Acremonium pyomyositis in a pediatric patient with acute leukemia. Pediatr Blood Cancer. 2005;44:521–4.PubMedCrossRefGoogle Scholar
  4. 48.
    Yamazaki R, Mori T, Aisa Y, et al. Systemic infection due to Acremonium after allogeneic peripheral blood stem cell transplantation. Intern Med. 2006;45:989–90.PubMedCrossRefGoogle Scholar
  5. 49.
    Foell JL, Fischer M, Seibold M, et al. Lethal double infection with Acremonium strictum and Aspergillus fumigates during induction chemotherapy in a child with all. Pediatr Blood Cancer. 2007;49(6):858–61.PubMedCrossRefGoogle Scholar
  6. 50.
    Mattei D, Mordini N, Lo Nigro C, et al. Successful treatment of Acrenomium-Fungämien mit voriconazol. Mycoses. 2003;46:511–4.PubMedCrossRefGoogle Scholar
  7. 51.
    Van Etta LL, Peterson LR, Gerding DN. Acremonium falciforme (Cephalosporium falciforme) mycetoma in a renal transplant patient. Arch Dermatol. 1983;119:707–8.PubMedCrossRefGoogle Scholar
  8. 52.
    Geyer AS, Fox LP, Husain S, Della-Latta P, Grossman ME. Acremonium mycetoma in a heart transplant recipient. J Am Acad Dermatol. 2006;55:1095–100.PubMedCrossRefGoogle Scholar


  1. 53.
    Ragge NK, Dean Hart JC, Easty DL, Tyers AG. A case of fungal keratitis caused by Scopulariopsis brevicaulis: treatment with antifungal agents and penetrating heratoplasty. Br J Ophthalmol. 1990;74:561–2.PubMedCrossRefGoogle Scholar
  2. 54.
    Gupta AK, Elewski BE. Nondermatophyte causes of onychomycosis and superficial mycoses. Curr Top Med Mycol. 1996;7:87–97.PubMedGoogle Scholar
  3. 55.
    Sellier P, Monsuez JJ, Lacroix C, et al. Recurrent subcutaneous infection due to Scopulariopsis brevicaulis in a liver transplant recipient. Clin Infect Dis. 2000;30:820–3.PubMedCrossRefGoogle Scholar
  4. 56.
    Neglia JP, Hurd DD, Ferrieri P, Snover DC. Invasive Scopulariopsis in the immunocompromised host. Am J Med. 1987;83:1163–6.PubMedCrossRefGoogle Scholar
  5. 57.
    Steinbach WJ, Schell WA, Miller JL, Perfect JR, Martin PL. Fatal Scopulariopsis brevicaulis infection in a paediatruc stem-cell transplant pateine treated with voriconazole and caspofungin and a review of Scopulariopsis infections in immunocompromised patients. J Infect. 2004;48:112–6.PubMedCrossRefGoogle Scholar
  6. 58.
    Patel R, Gustaferro CA, Krom RA, et al. Phaeohyphomycosis due to Scopulariopsis brumptii in a liver transplant recipient. Clin Infect Dis. 1994;19:198–200.PubMedCrossRefGoogle Scholar
  7. 59.
    Karam A, Hery G, Eveillard JR, et al. Subcutaneous mycosis due to Scopulariopsis brevicaulis in an aplastic patient. Ann Dermatol Venereol. 2003;130:783–6.PubMedGoogle Scholar
  8. 60.
    Martel J, Faisant M, Lebeau B, et al. Subcutaneous mycosis due to Scopulariopsis brevicaulis in an immunocompromised patient. Ann Dermatol Venereol. 2001;128:130–3.PubMedGoogle Scholar
  9. 61.
    Phillips P, Wood WS, Phillips G, Rinaldi MG. Invasive hyalohyphomycosis caused by Scopulariopsis brevicaulis in a patient undergoing allogeneic bone marrow transplant. Diagn Microbiol Infect Dis. 1989;12:429–32.PubMedCrossRefGoogle Scholar


  1. 62.
    Girmenia C, Pagano L, Martino B, et al. Invasive infections caused by Trichosporon species and Geotrichum capitatum in patients with hematological malignancies: a retrospective multicenter study from Italy and review of the literature. J Clin Microbiol. 2005;43:1818–28.PubMedCrossRefGoogle Scholar
  2. 63.
    Takamura S, Oono T, Kanzaki H, Arata J. Disseminated trichosporonosis with Trichosponon asahii. Eur J Dermatol. 1999;9:577–9.PubMedGoogle Scholar
  3. 64.
    Wynne SM, Kwon-Chung KJ, Shea YR, et al. Invasive infection with Trichosporon inkin in 2 siblings with chronic granulomatous disease. J Allergy Clin Immunol. 2004;114:1418–24.PubMedCrossRefGoogle Scholar
  4. 65.
    Reichenbach J, Lopatin U, Mahlaoui N. Actinomyces in chronic granulomatous disease: an emerging and unanticipated pathogen. Clin Infect Dis. 2009;49:1703–9.PubMedCrossRefGoogle Scholar
  5. 66.
    Hoy J, Hsu KC, Rolston K, Luna M, Bodey GP. Trichosporon beigelii infection: a review. Rev Infect Dis. 1986;8:959–67.PubMedCrossRefGoogle Scholar
  6. 67.
    Fournier S, Pavageau W, Feuillhade M, et al. Use of voriconazole to successfully treat disseminated Trichosporon asahii infection in a patient with acute myeloid leukaemia. Eur J Clin Microbiol Infect Dis. 2002;21:892–6.PubMedGoogle Scholar
  7. 68.
    Nahass GT, Rosenberg SP, Leonardi CL, Penneys NS. Disseminated infection with Trichosporon beigelii. Arch Dermatol. 1993;129:1020–3.PubMedCrossRefGoogle Scholar
  8. 69.
    Libertin CR, Davies NJ, Halper J, Edson RS, Roberts GD. Invasive disease caused by Trichosporon beigelii. Mayo Clin Proc. 1983;58:684–6.PubMedGoogle Scholar
  9. 70.
    Hughes CE, Serstock D, Wilson BD, Payne W. Infection with Trichosporon pullulans. Ann Intern Med. 1988;108:772–3.PubMedGoogle Scholar
  10. 71.
    Gold JW, Poston W, Mertelsmann R, et al. Systemic infection with Trichosporon cutaneum in a patient with acute leukemia. Cancer. 1981;48:2163–7.PubMedCrossRefGoogle Scholar
  11. 72.
    Winston DJ, Blasley GE, Rhodes J, Linne SR. Disseminated Trichosporon capitatum infection in an immunosuppressed host. Arch Intern Med. 1977;137:1192–5.PubMedCrossRefGoogle Scholar
  12. 73.
    Walsh TJ, Newman KR, Moody M, Wharton RC, Wade JC. Trichos­poronosis in patients with neoplastic disease. Medicine. 1986;65:268–79.PubMedCrossRefGoogle Scholar
  13. 74.
    Song HJ, Chung SL, Lee KS. Trichosporon in skin subcutaneous infection in a rheumatoid arthritis patient. Int J Dermatol. 2007;46:282–3.PubMedCrossRefGoogle Scholar
  14. 75.
    Fekkar A, Brun S, D’Ussel M, et al. Serum cross-reactivity with Aspergillus galactonmannan and cryptococcal antigen during fatal disseminated Trichonsporon dermatis infection. Clin Infect Dis. 2009;49:1457–8.PubMedCrossRefGoogle Scholar


  1. 76.
    De Miguel D, Gómez P, González R, et al. Nonfatal pulmonary Trichoderma viride infection in an adult patient with acute myeloid leukemia: report of one case and review of the literature. Diagn Microbiol Infect Dis. 2005;53:33–7.PubMedCrossRefGoogle Scholar
  2. 77.
    Chouaki T, Lavarde V, Lachaud L, Raccurt CP, Hennequin C. Invasive infections due to Trichoderma species: report of 2 cases, findins of in vitro susceptibility testing, and review of the literature. Clin Infect Dis. 2002;35:1360–7.PubMedCrossRefGoogle Scholar
  3. 78.
    Gautheret A, Dromer F, Bourhis JH, Andremont A. Trichoderma pseudokoningii as a cause of fatal infection in bone marrow transplant recipient. Clin Infect Dis. 1995;20:1060–3.CrossRefGoogle Scholar
  4. 79.
    Munoz FM, Demmler GJ, Travis WR, et al. Trichoderma longibrachiatum infection in a pediatric patient with aplastic anemia. J Clin Microbiol. 1997;35:499–503.PubMedGoogle Scholar
  5. 80.
    Kantarcioğlu AS, Celkan T, Yücel A, et al. Fatal Trichoderma harzianum infection in a leukemic pediatric patient. Med Mycol. 2009;47:207–15.PubMedCrossRefGoogle Scholar
  6. 81.
    Richter S, Cormican MG, Pfaller MA, et al. Fatal disseminated Trichoderma longibrachiatum infection in an adult bone marrow transplant patient: species identification and review of the literature. J Clin Microbiol. 1999;37:1154–60.PubMedGoogle Scholar
  7. 82.
    Myoken Y, Sugata T, Fujita Y, et al. Fatal necrotizing stomatitis due to Trichoderma longibrachiatum in a neutropenic patient with malignant lymphoma: a case report. Int J Oral Maxillofac Surg. 2002;31:688–91.PubMedCrossRefGoogle Scholar

Blastochizomyces capitatum

  1. 83.
    Martino R, Salavert M, Parody R, et al. Blastoschizomyces capitatus infection in patients with leukemia: report of 26 cases. Clin Infect Dis. 2004;38:335–41.PubMedCrossRefGoogle Scholar
  2. 84.
    Etienne A, Datry A, Gaspar N, et al. Successful treatment of disseminated Geotrichum capitatum infection with a combination of caspofungin and voriconazole in an immunocompromised patient. Mycoses. 2008;54:270–2.CrossRefGoogle Scholar
  3. 85.
    Pérez-Sanchez I, Anguita J, Martín-Rabadan P, et al. Blastoschizomyces capitatus infection in acute leukemia patients. Leuk Lymphoma. 2000;39:209–12.PubMedCrossRefGoogle Scholar
  4. 86.
    Kassamali H, Anaissie E, Ro J, et al. Disseminated Geotrichum candidum infection. J Clin Microbiol. 1987;25:1782–3.PubMedGoogle Scholar
  5. 87.
    Huang CL, Lu MY, Lin KH, Huang LM. Geotrichum candidum fungemia with skin lesions similar to varicella in a patient with acute lymphocytic leukemia. Acta Paediatr Taiwan. 2004;45:38–40.PubMedGoogle Scholar

Paracoccidioidomycosis (South American Blastomycosis)

  1. 88.
    Goldani LZ, Sugar AM. Paracoccidioidomycosis and AIDS: an overview. Clin Infect Dis. 1995;21(5):1275–81.PubMedCrossRefGoogle Scholar
  2. 89.
    Silva-Vergara ML, Teixeira AC, Curi VG, et al. Paracoccidioidomycosis associated with human immunodeficiency virus infection. Report of 10 cases. Med Mycol. 2003;41(3):259–63.PubMedCrossRefGoogle Scholar
  3. 90.
    Zavascki AP, Bienardt JC, Severo LC. Paracoccidioidomycosis in organ transplant recipient: case report. Rev Inst Med Trop Sao Paulo. 2004;46(5):279–81.PubMedCrossRefGoogle Scholar
  4. 91.
    Paniago AM, de Freitas AC, Aguiar ES, et al. Paracoccidioidomycosis in patients with human immunodeficiency virus: review of 12 cases observed in an endemic region in Brazil. J Infect. 2005;51(3):248–52.PubMedCrossRefGoogle Scholar
  5. 92.
    Morejón KM, Machado AA, Martinez R. Paracoccidioidomycosis in patients infected with and not infected with human immunodeficiency virus: a case-control study. Am J Trop Med Hyg. 2009;80(3):359–66.PubMedGoogle Scholar
  6. 93.
    Almeida OP, Jacks Jr J, Scully C. Paracoccidioidomycosis of the mouth: an emerging deep mycosis. Crit Rev Oral Biol Med. 2003;14(5):377–83. Review.PubMedCrossRefGoogle Scholar
  7. 94.
    Brunaldi MO, Rezende RE, Zucoloto S, et al. Co-infection with paracoccidioidomycosis and human immunodeficiency virus: report of a case with esophageal involvement. Am J Trop Med Hyg. 2010;82(6):1099–101.PubMedCrossRefGoogle Scholar

Copyright information

© Springer Science+Business Media, LLC 2012

Authors and Affiliations

  • Marc E. Grossman
    • 1
  • Lindy P. Fox
    • 2
  • Carrie Kovarik
    • 3
  • Misha Rosenbach
    • 4
  1. 1.New York Presbyterian HospitalColumbia University Medical CenterNew YorkUSA
  2. 2.University of California, San FranciscoSan FranciscoUSA
  3. 3.Dermatopathology, and Infectious DiseasesUniversity of PennsylvaniaPhiladelphiaUSA
  4. 4.University of PennsylvaniaPhiladelphiaUSA

Personalised recommendations